Data as of Apr 17
| -0.17 / -0.23%|
The 23 analysts offering 12-month price forecasts for CVS Caremark Corp have a median target of 77.00, with a high estimate of 87.00 and a low estimate of 66.00. The median estimate represents a +4.42% increase from the last price of 73.74.
The current consensus among 27 polled investment analysts is to Buy stock in CVS Caremark Corp. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.